The present invention relates to 4-[4-({[4-chloro-3-(trifluoromethyl) phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carbo xamide monohydrate, to processes for its preparation, to pharmaceutical compositions comprising it and to its use in the control of disorders.本發明係關於4-[4-({[4-氯-3-(三氟甲基)苯基]胺甲醯基}胺基)-3-氟苯氧基]-N-甲基吡啶-2-羧醯胺單水合物,其製備方法,包含其之醫藥組成物以及其用於控制疾病的用途。